<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2020-10-07" version="199">
<accession>Q02447</accession>
<accession>A0AVL9</accession>
<accession>B4E2B7</accession>
<accession>Q69B26</accession>
<accession>Q69B27</accession>
<accession>Q8TD56</accession>
<accession>Q8WWU4</accession>
<accession>Q9BQR1</accession>
<name>SP3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription factor Sp3</fullName>
</recommendedName>
<alternativeName>
<fullName>SPR-2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SP3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="J. Biochem. Mol. Biol." volume="35" first="273" last="282">
<title>AUA as a translation initiation site in vitro for the human transcription factor Sp3.</title>
<authorList>
<person name="Hernandez E.M."/>
<person name="Johnson A."/>
<person name="Notario V."/>
<person name="Chen A."/>
<person name="Richert J.R."/>
</authorList>
<dbReference type="PubMed" id="12297010"/>
<dbReference type="DOI" id="10.5483/bmbrep.2002.35.3.273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>VARIANT ALA-164</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Gene" volume="341" first="235" last="247">
<title>Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.</title>
<authorList>
<person name="Moran K.M."/>
<person name="Crusio R.H."/>
<person name="Chan C.H."/>
<person name="Grekova M.C."/>
<person name="Richert J.R."/>
</authorList>
<dbReference type="PubMed" id="15474306"/>
<dbReference type="DOI" id="10.1016/j.gene.2004.06.055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 6)</scope>
<scope>ALTERNATIVE INITIATION (ISOFORMS 2; 3 AND 4)</scope>
<scope>VARIANT ALA-164</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Mol. Biol. Evol." volume="19" first="2026" last="2029">
<title>5' genomic structure of human Sp3.</title>
<authorList>
<person name="Oleksiak M.F."/>
<person name="Crawford D.L."/>
</authorList>
<dbReference type="PubMed" id="12411611"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.molbev.a004026"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-135</scope>
</reference>
<reference key="6">
<citation type="submission" date="2001-03" db="EMBL/GenBank/DDBJ databases">
<title>Regulation of hTERT-gene transcription by SP3.</title>
<authorList>
<person name="Meyer-Grahle U."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 13-112</scope>
</reference>
<reference key="7">
<citation type="submission" date="2001-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Kingsley C."/>
<person name="Winoto A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 71-781</scope>
<scope>SEQUENCE REVISION</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="4251" last="4261">
<title>Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression.</title>
<authorList>
<person name="Kingsley C."/>
<person name="Winoto A."/>
</authorList>
<dbReference type="PubMed" id="1341900"/>
<dbReference type="DOI" id="10.1128/mcb.12.10.4251"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 129-781</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="Nucleic Acids Res." volume="20" first="5519" last="5525">
<title>Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.</title>
<authorList>
<person name="Hagen G."/>
<person name="Mueller S."/>
<person name="Beato M."/>
<person name="Suske G."/>
</authorList>
<dbReference type="PubMed" id="1454515"/>
<dbReference type="DOI" id="10.1093/nar/20.21.5519"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 85-781</scope>
<scope>VARIANT ALA-164</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Nucleic Acids Res." volume="25" first="3712" last="3717">
<title>Sp3 is a transcriptional activator of the human alpha2(I) collagen gene.</title>
<authorList>
<person name="Ihn H."/>
<person name="Trojanowska M."/>
</authorList>
<dbReference type="PubMed" id="9278495"/>
<dbReference type="DOI" id="10.1093/nar/25.18.3712"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="19573" last="19580">
<title>Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene.</title>
<authorList>
<person name="Ding H."/>
<person name="Benotmane A.M."/>
<person name="Suske G."/>
<person name="Collen D."/>
<person name="Belayew A."/>
</authorList>
<dbReference type="PubMed" id="10391891"/>
<dbReference type="DOI" id="10.1074/jbc.274.28.19573"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HLTF</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Nucleic Acids Res." volume="29" first="4994" last="5000">
<title>Transcription factor Sp3 is regulated by acetylation.</title>
<authorList>
<person name="Braun H."/>
<person name="Koop R."/>
<person name="Ertmer A."/>
<person name="Nacht S."/>
<person name="Suske G."/>
</authorList>
<dbReference type="PubMed" id="11812829"/>
<dbReference type="DOI" id="10.1093/nar/29.24.4994"/>
</citation>
<scope>ACETYLATION AT LYS-551</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 551-LYS--GLU-557</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="35783" last="35786">
<title>The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2.</title>
<authorList>
<person name="Sun J.M."/>
<person name="Chen H.Y."/>
<person name="Moniwa M."/>
<person name="Litchfield D.W."/>
<person name="Seto E."/>
<person name="Davie J.R."/>
</authorList>
<dbReference type="PubMed" id="12176973"/>
<dbReference type="DOI" id="10.1074/jbc.c200378200"/>
</citation>
<scope>INTERACTION WITH HDAC1 AND HDAC2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Mol. Cell" volume="10" first="831" last="842">
<title>SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization.</title>
<authorList>
<person name="Ross S."/>
<person name="Best J.L."/>
<person name="Zon L.I."/>
<person name="Gill G."/>
</authorList>
<dbReference type="PubMed" id="12419227"/>
<dbReference type="DOI" id="10.1016/s1097-2765(02)00682-2"/>
</citation>
<scope>SUMOYLATION AT LYS-120 AND LYS-551</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-120 AND LYS-551</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="35775" last="35780">
<title>Acetylated SP3 is a transcriptional activator.</title>
<authorList>
<person name="Ammanamanchi S."/>
<person name="Freeman J.W."/>
<person name="Brattain M.G."/>
</authorList>
<dbReference type="PubMed" id="12837748"/>
<dbReference type="DOI" id="10.1074/jbc.m305961200"/>
</citation>
<scope>INTERACTION WITH HDAC1 AND EP300</scope>
<scope>ACETYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="42095" last="42105">
<title>Complexity of translationally controlled transcription factor Sp3 isoform expression.</title>
<authorList>
<person name="Sapetschnig A."/>
<person name="Koch F."/>
<person name="Rischitor G."/>
<person name="Mennenga T."/>
<person name="Suske G."/>
</authorList>
<dbReference type="PubMed" id="15247228"/>
<dbReference type="DOI" id="10.1074/jbc.m404989200"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>ALTERNATIVE PRODUCTS</scope>
<scope>LACK OF GLYCOSYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Cell. Signal." volume="17" first="153" last="166">
<title>Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.</title>
<authorList>
<person name="Spengler M.L."/>
<person name="Kennett S.B."/>
<person name="Moorefield K.S."/>
<person name="Simmons S.O."/>
<person name="Brattain M.G."/>
<person name="Horowitz J.M."/>
</authorList>
<dbReference type="PubMed" id="15494207"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2004.06.007"/>
</citation>
<scope>SUMOYLATION AT LYS-551</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 551-LYS--GLU-553</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Biochem. J." volume="387" first="737" last="745">
<title>Sp3 is involved in the regulation of SOCS3 gene expression.</title>
<authorList>
<person name="Ehlting C."/>
<person name="Haussinger D."/>
<person name="Bode J.G."/>
</authorList>
<dbReference type="PubMed" id="15554904"/>
<dbReference type="DOI" id="10.1042/bj20041101"/>
</citation>
<scope>ACETYLATION AT LYS-551</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Gene" volume="379" first="68" last="78">
<title>The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoter.</title>
<authorList>
<person name="Ellis D.J."/>
<person name="Dehm S.M."/>
<person name="Bonham K."/>
</authorList>
<dbReference type="PubMed" id="16781829"/>
<dbReference type="DOI" id="10.1016/j.gene.2006.04.015"/>
</citation>
<scope>SUMOYLATION AT LYS-551</scope>
<scope>FUNCTION OF ISOFORMS</scope>
<scope>MUTAGENESIS OF LYS-551</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="FASEB J." volume="21" first="3386" last="3397">
<title>Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1.</title>
<authorList>
<person name="Wooten-Blanks L.G."/>
<person name="Song P."/>
<person name="Senkal C.E."/>
<person name="Ogretmen B."/>
</authorList>
<dbReference type="PubMed" id="17548428"/>
<dbReference type="DOI" id="10.1096/fj.07-8621com"/>
</citation>
<scope>FUNCTION</scope>
<scope>DEACETYLATION</scope>
<scope>INTERACTION WITH HDAC1</scope>
<scope>MUTAGENESIS OF LYS-551</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Adv. Enzyme Regul." volume="48" first="189" last="208">
<title>Nuclear organization and chromatin dynamics -- Sp1, Sp3 and histone deacetylases.</title>
<authorList>
<person name="Davie J.R."/>
<person name="He S."/>
<person name="Li L."/>
<person name="Sekhavat A."/>
<person name="Espino P."/>
<person name="Drobic B."/>
<person name="Dunn K.L."/>
<person name="Sun J.M."/>
<person name="Chen H.Y."/>
<person name="Yu J."/>
<person name="Pritchard S."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="18187045"/>
<dbReference type="DOI" id="10.1016/j.advenzreg.2007.11.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="EMBO Rep." volume="9" first="899" last="906">
<title>SUMO-modified Sp3 represses transcription by provoking local heterochromatic gene silencing.</title>
<authorList>
<person name="Stielow B."/>
<person name="Sapetschnig A."/>
<person name="Wink C."/>
<person name="Kraeger I."/>
<person name="Suske G."/>
</authorList>
<dbReference type="PubMed" id="18617891"/>
<dbReference type="DOI" id="10.1038/embor.2008.127"/>
</citation>
<scope>SUMOYLATION AT LYS-551</scope>
<scope>FUNCTION OF ISOFORMS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73; SER-563 AND SER-646</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="3723" last="3733">
<title>Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.</title>
<authorList>
<person name="Bjerke G.A."/>
<person name="Hyman-Walsh C."/>
<person name="Wotton D."/>
</authorList>
<dbReference type="PubMed" id="21746878"/>
<dbReference type="DOI" id="10.1128/mcb.01456-10"/>
</citation>
<scope>INTERACTION WITH MEIS2 AND PBX1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-551</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-551</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-551</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-551</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-551 AND LYS-593</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2019" name="Cell. Mol. Life Sci.">
<title>The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs.</title>
<authorList>
<person name="Piskacek M."/>
<person name="Havelka M."/>
<person name="Jendruchova K."/>
<person name="Knight A."/>
<person name="Keegan L.P."/>
</authorList>
<dbReference type="PubMed" id="31375868"/>
<dbReference type="DOI" id="10.1007/s00018-019-03251-w"/>
</citation>
<scope>9AATAD MOTIF</scope>
</reference>
<comment type="function">
<text evidence="13 14 17 18 20 22 23 24 25 26 27 30">Transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. Binds to GT and GC boxes promoter elements. Competes with SP1 for the GC-box promoters. Weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping.</text>
</comment>
<comment type="subunit">
<text evidence="13 15 18 25 28">Interacts with HLTF; the interaction may be required for basal transcriptional activity of HLTF. Interacts with HDAC1; the interaction deacetylates SP3 and regulates its transcriptional activity. Interacts with HDAC2 (preferably the CK2-phosphorylated form); the interaction deacetylates SP3 and regulates its transcriptional activity. Interacts with MEIS2 isoform 4 and PBX1 isoform PBX1a.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-10292696">
<id>Q96Q77</id>
<label>CIB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-1389411">
<id>Q6MZP7</id>
<label>LIN54</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-745085">
<id>Q96BD5</id>
<label>PHF21A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-1389308">
<id>Q7Z3K3</id>
<label>POGZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-372475">
<id>P14678-2</id>
<label>SNRPB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348158">
<id>Q02447</id>
</interactant>
<interactant intactId="EBI-12023934">
<id>Q5MJ10</id>
<label>SPANXN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Localizes to the nuclear periphery and in nuclear dots when sumoylated. Some localization in PML nuclear bodies.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>Q02447-1</id>
<name>1</name>
<name>Large</name>
<name>L-Sp3</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q02447-2</id>
<name>2</name>
<sequence type="described" ref="VSP_026701"/>
</isoform>
<isoform>
<id>Q02447-3</id>
<name>3</name>
<name>M1-Sp3</name>
<sequence type="described" ref="VSP_026699"/>
</isoform>
<isoform>
<id>Q02447-4</id>
<name>4</name>
<name>M2-Sp3</name>
<sequence type="described" ref="VSP_026698"/>
</isoform>
<isoform>
<id>Q02447-5</id>
<name>5</name>
<sequence type="described" ref="VSP_026700"/>
</isoform>
<isoform>
<id>Q02447-6</id>
<name>6</name>
<sequence type="described" ref="VSP_026701 VSP_026702"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Ubiquitously expressed.</text>
</comment>
<comment type="domain">
<text evidence="29">The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.</text>
</comment>
<comment type="PTM">
<text>Not glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="14 17 18 22 23 24 27">Acetylated by histone acetyltransferase p300, deacetylated by HDACs. Acetylation/deacetylation states regulate transcriptional activity. Acetylation appears to activate transcription. Alternate sumoylation and acetylation at Lys-551 also control transcriptional activity. Ceramides can also regulate acetylation/deacetylation events through altering the interaction of HDAC with SP3. In vitro, C(18)-ceramides, but not C(16)-ceramides, increase the interaction of HDAC1 with SP3 and enhance the deacetylation of SP3 and the subsequent repression of the TERT promoter.</text>
</comment>
<comment type="PTM">
<text evidence="14 17 18 22 23 24 27">Sumoylated on all isoforms. Sumoylated on 2 sites in longer isoforms with Lys-551 being the major site. Sumoylation at this site promotes nuclear localization to the nuclear periphery, nuclear dots and PML nuclear bodies. Sumoylation on Lys-551 represses the transactivation activity, except for the largest isoform, L-Sp3, which has little effect on transactivation. Alternate sumoylation and acetylation at Lys-551 also control transcriptional activity.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="34">Produced by alternative initiation at Met-13 of isoform 1.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="34">Produced by alternative initiation at Met-286 of isoform 1.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 4</molecule>
<text evidence="34">Produced by alternative initiation at Met-303 of isoform 1.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 5</molecule>
<text evidence="34">Produced by alternative splicing. An AUA codon is translated into Met and used as a translation initiation site (in vitro).</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 6</molecule>
<text evidence="34">Produced by alternative splicing.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the Sp1 C2H2-type zinc-finger protein family.</text>
</comment>
<dbReference type="EMBL" id="AY070137">
<property type="protein sequence ID" value="AAL58086.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY441957">
<property type="protein sequence ID" value="AAR30505.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY441958">
<property type="protein sequence ID" value="AAR30506.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304199">
<property type="protein sequence ID" value="BAG65079.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126414">
<property type="protein sequence ID" value="AAI26415.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF494280">
<property type="protein sequence ID" value="AAM12875.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ310752">
<property type="protein sequence ID" value="CAC34575.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M97191">
<property type="protein sequence ID" value="AAA36630.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X68560">
<property type="protein sequence ID" value="CAA48562.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2254.1">
<molecule id="Q02447-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46452.1">
<molecule id="Q02447-5"/>
</dbReference>
<dbReference type="PIR" id="B44489">
<property type="entry name" value="B44489"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001017371.3">
<molecule id="Q02447-5"/>
<property type="nucleotide sequence ID" value="NM_001017371.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001166183.1">
<property type="nucleotide sequence ID" value="NM_001172712.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003102.1">
<molecule id="Q02447-1"/>
<property type="nucleotide sequence ID" value="NM_003111.4"/>
</dbReference>
<dbReference type="SMR" id="Q02447"/>
<dbReference type="BioGRID" id="112553">
<property type="interactions" value="57"/>
</dbReference>
<dbReference type="ELM" id="Q02447"/>
<dbReference type="IntAct" id="Q02447">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="Q02447"/>
<dbReference type="STRING" id="9606.ENSP00000310301"/>
<dbReference type="GlyGen" id="Q02447">
<property type="glycosylation" value="4 sites, 1 O-linked glycan (4 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q02447"/>
<dbReference type="PhosphoSitePlus" id="Q02447"/>
<dbReference type="BioMuta" id="SP3"/>
<dbReference type="DMDM" id="30923147"/>
<dbReference type="EPD" id="Q02447"/>
<dbReference type="jPOST" id="Q02447"/>
<dbReference type="MassIVE" id="Q02447"/>
<dbReference type="MaxQB" id="Q02447"/>
<dbReference type="PaxDb" id="Q02447"/>
<dbReference type="PeptideAtlas" id="Q02447"/>
<dbReference type="PRIDE" id="Q02447"/>
<dbReference type="ProteomicsDB" id="58091">
<molecule id="Q02447-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58092">
<molecule id="Q02447-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58093">
<molecule id="Q02447-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58094">
<molecule id="Q02447-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58095">
<molecule id="Q02447-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58096">
<molecule id="Q02447-6"/>
</dbReference>
<dbReference type="Antibodypedia" id="3887">
<property type="antibodies" value="399 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6670"/>
<dbReference type="Ensembl" id="ENST00000310015">
<molecule id="Q02447-1"/>
<property type="protein sequence ID" value="ENSP00000310301"/>
<property type="gene ID" value="ENSG00000172845"/>
</dbReference>
<dbReference type="GeneID" id="6670"/>
<dbReference type="KEGG" id="hsa:6670"/>
<dbReference type="UCSC" id="uc002uig.3">
<molecule id="Q02447-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6670"/>
<dbReference type="DisGeNET" id="6670"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000172845.13"/>
<dbReference type="GeneCards" id="SP3"/>
<dbReference type="HGNC" id="HGNC:11208">
<property type="gene designation" value="SP3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000172845">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601804">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q02447"/>
<dbReference type="OpenTargets" id="ENSG00000172845"/>
<dbReference type="PharmGKB" id="PA36045"/>
<dbReference type="eggNOG" id="KOG1721">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155099"/>
<dbReference type="InParanoid" id="Q02447"/>
<dbReference type="KO" id="K09193"/>
<dbReference type="OMA" id="QQVPIQT"/>
<dbReference type="PhylomeDB" id="Q02447"/>
<dbReference type="TreeFam" id="TF350150"/>
<dbReference type="PathwayCommons" id="Q02447"/>
<dbReference type="Reactome" id="R-HSA-3232118">
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="SignaLink" id="Q02447"/>
<dbReference type="SIGNOR" id="Q02447"/>
<dbReference type="BioGRID-ORCS" id="6670">
<property type="hits" value="55 hits in 890 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SP3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Sp3_transcription_factor"/>
<dbReference type="GenomeRNAi" id="6670"/>
<dbReference type="Pharos" id="Q02447">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q02447"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q02447">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000172845">
<property type="expression patterns" value="Expressed in amniotic fluid and 251 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q02447">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q02447">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017053">
<property type="term" value="C:transcription repressor complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060216">
<property type="term" value="P:definitive hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048596">
<property type="term" value="P:embryonic camera-type eye morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001892">
<property type="term" value="P:embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060136">
<property type="term" value="P:embryonic process involved in female pregnancy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048706">
<property type="term" value="P:embryonic skeletal system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043353">
<property type="term" value="P:enucleate erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030851">
<property type="term" value="P:granulocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030219">
<property type="term" value="P:megakaryocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030224">
<property type="term" value="P:monocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001779">
<property type="term" value="P:natural killer cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001829">
<property type="term" value="P:trophectodermal cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR030452">
<property type="entry name" value="SP3"/>
</dbReference>
<dbReference type="InterPro" id="IPR036236">
<property type="entry name" value="Znf_C2H2_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013087">
<property type="entry name" value="Znf_C2H2_type"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23235:SF3">
<property type="entry name" value="PTHR23235:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00096">
<property type="entry name" value="zf-C2H2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00355">
<property type="entry name" value="ZnF_C2H2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57667">
<property type="entry name" value="SSF57667"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00028">
<property type="entry name" value="ZINC_FINGER_C2H2_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50157">
<property type="entry name" value="ZINC_FINGER_C2H2_2"/>
<property type="match status" value="3"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Transcription factor Sp3" id="PRO_0000047141">
<location>
<begin position="1"/>
<end position="781"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 1" evidence="12">
<location>
<begin position="621"/>
<end position="645"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 2" evidence="12">
<location>
<begin position="651"/>
<end position="675"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 3" evidence="12">
<location>
<begin position="681"/>
<end position="703"/>
</location>
</feature>
<feature type="region of interest" description="Transactivation domain (Gln-rich)">
<location>
<begin position="138"/>
<end position="237"/>
</location>
</feature>
<feature type="region of interest" description="Transactivation domain (Gln-rich)">
<location>
<begin position="350"/>
<end position="499"/>
</location>
</feature>
<feature type="region of interest" description="Repressor domain">
<location>
<begin position="534"/>
<end position="620"/>
</location>
</feature>
<feature type="short sequence motif" description="9aaTAD" evidence="29">
<location>
<begin position="461"/>
<end position="469"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="21"/>
<end position="31"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="35"/>
<end position="39"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ala-rich">
<location>
<begin position="44"/>
<end position="100"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3 4 5">
<location>
<position position="73"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="14 23">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="563"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="566"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="646"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="17">
<location>
<position position="120"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="551"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="6">
<location>
<position position="551"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="7 8 9 10">
<location>
<position position="551"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="593"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_026698" evidence="34">
<location>
<begin position="1"/>
<end position="302"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_026699" evidence="34">
<location>
<begin position="1"/>
<end position="285"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_026700" evidence="31">
<original>MTAPEKPVKQEEMAALDVDSGGGGGGGGGHGEYLQQQQQHGNGAVAAAAAAQDTQPSPLALLAATCSKI</original>
<variation>M</variation>
<location>
<begin position="1"/>
<end position="69"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 6." id="VSP_026701" evidence="32 33">
<location>
<begin position="1"/>
<end position="12"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_026702" evidence="32">
<location>
<begin position="53"/>
<end position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1047640." id="VAR_016123" evidence="16 19 21">
<original>T</original>
<variation>A</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some loss of sumoylation. Slight increase in transcriptional activity. Large increase in transcriptional activity; when associated with R-551." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases transcriptional activity." evidence="22">
<original>KEE</original>
<variation>AAA</variation>
<location>
<begin position="551"/>
<end position="553"/>
</location>
</feature>
<feature type="mutagenesis site" description="200-fold increase in transcriptional activation." evidence="22">
<original>KEE</original>
<variation>REA</variation>
<location>
<begin position="551"/>
<end position="553"/>
</location>
</feature>
<feature type="mutagenesis site" description="200-fold increase in transcriptional activation." evidence="22">
<original>KEE</original>
<variation>RED</variation>
<location>
<begin position="551"/>
<end position="553"/>
</location>
</feature>
<feature type="mutagenesis site" description="200-fold increase in transcriptional activation.">
<original>KE</original>
<variation>RA</variation>
<location>
<begin position="551"/>
<end position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="200-fold increase in transcriptional activation.">
<original>KE</original>
<variation>RD</variation>
<location>
<begin position="551"/>
<end position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="A decreased interaction with HDAC1 and deacetylation of SP3. Increase of about 4.5% of activity of the TERT promoter. Decreased recruitment of HDAC1 and increased binding of RNA polymerase II with promoter DNA." evidence="17 24 25">
<original>K</original>
<variation>Q</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="mutagenesis site" description="Great loss of sumoylation, 20-fold increase in transcriptional activity and diffuse nuclear localization. Further small increase in transcriptional activity; when associated with R-120. Increased interaction with HDAC1 and deacetylation of SP3. About 50% decrease in activity of the TERT promoter. Enhances recruitment of HDAC1 and inhibits binding of RNA polymerase II with promoter DNA." evidence="17 24 25">
<original>K</original>
<variation>R</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAR30505." ref="2" evidence="34">
<original>I</original>
<variation>M</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAA36630." ref="7" evidence="34">
<original>P</original>
<variation>G</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAL58086, 2; AAR30505/AAR30506 and 8; CAA48562." ref="1 2 8" evidence="34">
<original>N</original>
<variation>K</variation>
<location>
<position position="739"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O70494"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00042"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391891"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11812829"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12176973"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297010"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12419227"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12837748"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1454515"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15247228"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15474306"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15494207"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15554904"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16781829"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17548428"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18187045"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18617891"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21746878"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31375868"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9278495"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12297010"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15474306"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="781" mass="81925" checksum="DCFD4363509DB49D" modified="2003-05-16" version="3">MTAPEKPVKQEEMAALDVDSGGGGGGGGGHGEYLQQQQQHGNGAVAAAAAAQDTQPSPLALLAATCSKIGPPSPGDDEEEAAAAAGAPAAAGATGDLASAQLGGAPNRWEVLSATPTTIKDEAGNLVQIPSAATSSGQYVLPLQNLQNQQIFSVAPGSDSSNGTVSSVQYQVIPQIQSADGQQVQIGFTGSSDNGGINQESSQIQIIPGSNQTLLASGTPSANIQNLIPQTGQVQVQGVAIGGSSFPGQTQVVANVPLGLPGNITFVPINSVDLDSLGLSGSSQTMTAGINADGHLINTGQAMDSSDNSERTGERVSPDINETNTDTDLFVPTSSSSQLPVTIDSTGILQQNTNSLTTSSGQVHSSDLQGNYIQSPVSEETQAQNIQVSTAQPVVQHLQLQESQQPTSQAQIVQGITPQTIHGVQASGQNISQQALQNLQLQLNPGTFLIQAQTVTPSGQVTWQTFQVQGVQNLQNLQIQNTAAQQITLTPVQTLTLGQVAAGGAFTSTPVSLSTGQLPNLQTVTVNSIDSAGIQLHPGENADSPADIRIKEEEPDPEEWQLSGDSTLNTNDLTHLRVQVVDEEGDQQHQEGKRLRRVACTCPNCKEGGGRGTNLGKKKQHICHIPGCGKVYGKTSHLRAHLRWHSGERPFVCNWMYCGKRFTRSDELQRHRRTHTGEKKFVCPECSKRFMRSDHLAKHIKTHQNKKGIHSSSTVLASVEAARDDTLITAGGTTLILANIQQGSVSGIGTVNTSATSNQDILTNTEIPLQLVTVSGNETME</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

